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The influence of solution composition on protein loss during
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FREDERICK N. MILLER, KARL D. NOLPH, MICHAEL I. SORKIN, and HANS J. GLOOR
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A number of recent studies in man [1—31 and rats [1, 4, 5] has
investigated the influence of the composition of commercial
peritoneal dialysis solutions on the microcirculation and on the
removal of solutes during peritoneal dialysis. One of those
studies [31 demonstrated that dialysis with a normal osmolality
Krebs solution greatly enhanced the concentration of protein in
the drainage solution in comparison to that obtained with
commercial, 1.5% dextrose solutions. We proposed that these
results represented an effect of osmolality on interstitial move-
ment of protein [61. Since protein movement in the interstitium
probably occurs through water channels in the gel-like matrix of
the interstitium [7, 8], a change to a high osmolality dialysis
solution could dehydrate the interstitium. This would increase
the resistance to protein movement and thus decrease the loss
of protein in the dialysate. During the first few exchanges, the
high osmolality of commercial dialysis solutions could also pull
residual protein out of the interstitium because it produced a
generalized dehydration of the interstitial tissues. This would
lead to large concentrations of protein in the drainage solution
during the first few exchanges and then a progressive fall in
dialysate protein with subsequent exchanges. An alternative
hypothesis to explain such results would be that there is simply
a washout of residual protein from the peritoneal cavity or from
tissue spaces within the cavity.
The following studies were designed to test which of these
two hypotheses, an increased resistance to protein movement
through dehydration of the interstitial tissue or a washout of
residual protein already present in the peritoneal cavity, could
explain our previous findings [31.
Methods
Clinical studies. The patient studies were performed on
sixteen patients who manifested stable cardiovascular systems
as reflected by their heart rate, blood pressure, and an electro-
cardiogram. Patients with cardiac arrhythmias, fluctuating
blood pressures, severe congestive heart failure, or peritonitis
were not accepted for this study. The patients used in the study
had chronic renal failure and were scheduled to be treated with
peritoneal dialysis. The patients did not experience any infec-
tions in these studies or any other major complications. All
studies were performed in the Clinical Research Center at the
University of Missouri Medical School. All patients gave in-
formed consent.
At least 2 days before the start of an experiment a chronic
indwelling Tenckhoff catheter was placed in the abdomen under
local anesthesia and peritoneal dialysis was begun. For all
experiments each exchange period consisted of the instillation
by gravity of 2 liters of a dialysis solution over a 10-mm period,
a 30-mm dwell period for the solution in the peritoneal cavity,
and a 20-mm period for draining the solution. This provided a
total exchange time of 60 mm. In each study, a series of six or
more exchanges with one type of solution were alternated with
a series of six to seven exchanges with another type. Each is
described in detail with the results.
During the dialysis studies, fluid intake by the patient approx-
imated net insensible and urine losses. Any negative water
balance during any dialysis exchange was replaced by a 0.5%
sodium chloride solution during the next dialysis exchange
period to prevent any significant volume depletion. For patients
who needed to lose sodium and water, a negative balance not to
exceed 10 ml/hr was permitted.
For clearance measurements, the total drainage volume per
exchange was measured and each dialysate was analyzed for
urea, creatinine, inulin, and total protein concentrations. Con-
centrations of urea, creatinine, and inulin in plasma were
measured periodically throughout an experiment, and extrapo-
lated values were used to calculate clearance. A standard mean
clearance rate (c mi/mm) during the exchange period was
calculated for urea (Curea), creatinine (Car), and inulin (C1) by
the formula: (Drainage volume/time) x (dialysate concentra-
tion/serum concentration). Creatinine and urea were measured
by Technicon autoanalyzer techniques. Inulin concentrations
were measured by the spectrophotometric technique of Brown
and Noiph [91 and proteins by the method of Henry, Sobel, and
Segalone [101.
The experiments consisted of three studies. Each study
compared two of three dialysis solutions: 1.5% Dianeal® and
two Krebs solutions. Both Krebs solutions contained 120 mri
NaC1, 20 mt NaHCO3, 3.1 mM KC1, 1.7mM CaC12 2 H20 and
1 mM MgCl2 6 H20. The first Krebs had 11.6 m dextrose and
the 1.5% Krebs contained 83.3 m dextrose. Table I lists the
three studies along with the major factors by which the solution
used in the studies differ.
The first study of five patients involves changes in osmolality,
pH, Pco2 (which is near 40 mm Hg in the bicarbonate solutions
and less than 10 mm Hg in commercial solutions), and buffer
anion. The second study, also of five patients, involves changes
in all of the above, except osmolality. The third study involves
six patients and examines changes in osmolality without
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Group Osmolality pH
5.6
Buffer anion
Lactate- 1.5% Dianeal —355
Krebs —290 7.4 Bicarbonate
2 - 1.5% Dianeal —355 5.6 Lactate
1.5% Krebs —355 7.4 Bicarbonate
3 - 1.5% Krebs —355 7.4 Bicarbonate
Krebs ——290 7.4 Bicarbonate
changes in pH, Pco7, or buffer anion, We have reported
previously that change in pH alone with a sodium hydroxide
addition to commercial solutions does not alter solute clear-
ances [2] and that changes in pH and Pco2 do not alter solution
vasoactivity [1, 4, 6].
Animal stadies. In the animal experiments Sprague-Dawley
rats (230 to 300 g) were anesthetized with a subcutaneous
injection of pentobarbital (50 mg/kg) and prepared for peritoncal
dialysis. The animals were placed on a heating pad and rectal
temperature was monitored and maintained at 37°C. Back heat
was kept below 40°C to avoid painful stimuli which could result
from overheating the animal. The left femorat artery was
cannulated for measurement and recording of arterial blood
pressure was done with a Statham pressure transducer and a
Brush recorder. A midline incision approximately 5-mm long
was made in the abdominal wall. Tygon tubing (3 mm OD, — 20
cm long) was inserted through this incision and the end of the
tubing placed near the left, rear wall of the peritoneal cavity.
The opening in the abdominal wall, around the Tygon tubing
eannula, was closed with a purse-string suture.
A modified Krebs solution (290 mOsm) was used as the
dialysis solution and contained 113 mM NaCI, 11.6 m Dex-
trose, 4.7 mM KCI, 1.2 mM MgSO4 '7 H20, 1.2 mrvt KH2 P04,
2.6 mat CaC12 2 H20, and 25 mat NaHCO3. It was kept heated
to 37°C and maintained at a pH = 7.4 and a Pco2 of 40 mm Hg
by bubbling carbon dioxide into the solution.
There were nine dialysis exchanges in each experiment. The
protocol for each exchange was similar to that used by Brown et
al [11]. The dialysis solution was instilled into the peritoneal
cavity (1 ml/lO g rat) in a 15-sec period. There was a dwell-time
in the peritoneal cavity of 12 mm, and then 3 mm were allowed
for gravity flow drainage of the dialysis solution into a 50-mI
graduated cylinder. The drainage volume was measured and
saved for analysis. After the first exchange, rat serum albumin
which had been conjugated with fluorescein isothioeynate
(FITC-RSA) by the method of Chadwick and Fothergill was
injected slowly through the femoral artery cannula 112]. Before
and after each series of exchanges, blood was collected in a
capillary tube via a small incision in the tail for hematocrit and
plasma FITC-RSA determinations.
Dialysate from each exchange was analyzed for FITC-RSA
concentration, urea concentration, total protein concentration,
and osmolality. FITC-RSA concentration was determined using
an Aminco Bowman Spectrophotofluorometer. Dialysate and
blood was analyzed for urea and protein by the same techniques
used in the clinical studies [9, 10].
In both human and rat studies for comparisons of three or
more groups, Duncan's new multiple range test with correction
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Fig. 1. A comparison qfsolonons during peritoneal dialysts diffr ring by
osmolality, pH, and buffer anion (see Toble I, group 1)..Seven
exchanges with a commercial solution were followed by seven ex-
changes with a Krebs solution and then another seven exchanges with
the commercial solution. The data (mean value 5EM) are given for
each seven exchange sequence. An asterisk (°) indicates a significant
difference from the first and third bars in each triad and was determined
by a paired t test. Symbols: E, commercial peritoneal dialysis solution
(355 mOsm); , Krehs dialysis solution (290 mOsm).
for differences in group size was used when group differences
were found by analysis of variance [13]. The Student's t test
was used for paired comparisons. Differences were considered
statistically different at P < 0.05.
Results
Clinical stadies. In the first set of clinical peritoneal dialysis
experiments (Table 1, group 1) the effects of commercial
peritoneal dialysis solution (lactate-buffered) at a high osmolali-
ty (355 mOsm) were compared to the effects of a Krebs dialysis
solution (bicarbonate buffer) at a normal osmolality (290
mOsm). The protocol consisted of seven exchanges of the
commercial solution followed by seven exchanges of the Krebs
solution and then another seven exchanges with the commercial
solution. The mean data for the five patients in this study are
shown in Figure 1. As expected, there was a decrease in
drainage volume during dialysis with the normal osmolality
Krehs solution. In addition, small solute clearances (urea and
creatinine) were decreased significantly with the normal osmo-
lality Krebs solution while there was a very large increase in
dialysate protein concentration (proportionately much higher
than can be attributed to the volume decrease).
In the second set of clinical experiments, the effects of the
commercial dialysis solution were compared to that of a high
osmolality (355 mOsm) Krebs solution in five patients. A group
of seven exchanges with the commercial solution (355 mOsm)
preceded and followed a group of seven exchanges with a high
osmolality Krebs solution (355 mOsm). Figure 2 gives the mean
data for this experiment. There were no significant changes in
dialysate volume, urea, creatinine, or inulin clearances, or
dialysate protein concentrations.
The third clinical group was used to compare the effects of a
high osmolality Krebs dialysis solution (355 mOsm) to a normal
osmolality Krebs dialysis solution (290 mOsm). In this study,
each patient underwent 12 exchanges on 2 different days. On
day 1, six exchanges with one of the solutions was followed by
six exchanges with the other solution. On study day 2, the order
of the solutions was reversed. The composite data in Figure 3
demonstrates that this difference in solution osmolality pro-
Table 1. Clinical studies comparing the use of different peritoneal
dialysis solutions
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Fig. 2. A comparison of solutions during peritoneal dialysis dfering by
pH and buffer anion (group 2). The same protocol was used as in Figure
I. There were no significant differences for any of the measured
parameters. Symbols: , commercial peritoneal dialysis solution (355
mOsm); , hyperosmolar Krebs dialysis solution (355 mOsm).
duced the expected decrease in drainage volume with the
normal osmolality solution but no changes in solute clearances.
Group 3 was also used to examine the change in dialysate
protein concentrations with progressive exchanges. The curves
shown in Figure 4 demonstrate that regardless of the osmolality
of the first dialysis solution used in the study there is a high
protein concentration in the first exchange which declines with
subsequent exchanges until a plateau is reached. Changing the
dialysis solution (at exchange 7) from a high to a normal or a
normal to a high osmolality solution did not effect this plateau
concentration of protein.
Animal studies. Data for the rat dialysis experiments is
depicted graphically in Figure 5. Total protein in the dialysate
(given in grams per milliliters per minute) is very high in the first
exchange but declines in the second, third, and fourth ex-
changes and then plateaus by the fifth exchange. In contrast,
the fluorescent-labeled albumin (FITC-RSA), which is injected
after the first exchange, has a slightly lower dialysate concen-
tration (given in nanograms per milliliters per minute) in the first
few exchanges and plateaus at about exchange seven. Blood
hematocrit, drainage volumes, and urea clearances were not
altered during these series of exchanges.
Discussion
The initial observation in these studies is shown in Figure 1.
There is a higher concentration of dialysate protein when Krebs
solution is used as the dialysis solution in comparison to that
obtained with 1.5% commercial dialysis solution. These data
imply that pH, buffer anion, osmolality or a combination of
these factors (Table 1) may be involved in the regulation of the
transfer of protein from the vasculature to the peritoneal cavity.
Others have shown that hyperosmolar solutions may increase
small solute clearances but the effects on dialysate protein
concentration were not examined in these studies [11, 14]. It
does appear that with the large solutes, osmolality may alter
solute clearances [3, 15, 16]. In comparisons of commercial
solutions that used either lactate or acetate buffering systems,
no differences were found for large or small solute clearances
[2]. It is also unlikely that changes in pH alone could account
for these data (Fig. 1) since pH adjustment does not effect
clinical clearances or vasodilatory effects of commercial solu-
tions [1, 5, 17]. Thus, of the major differences in solution
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Fig. 3. A series of 12 peritoneal dialysis exchanges (six with one solution
followed by six exchanges with a second solution) in each of six patients
on 2 different days (group 3). Data are presented as the mean value
SEM for all patients with each solution regardless of the day or order.
The only significant difference (paired t test) was in the drainage
volume. Symbols: , hyperosmolar Krebs dialysis solution (355
mOsm); , normal osmolar Krebs dialysis solution (290 mOsm).
composition for group 1, osmolality seemed most likely to be
involved in the altered protein concentrations found in the
dialysate.
In the second set of clinical experiments (group 2), the effects
of a commercial dialysis solution were compared to those with a
hyperosmolar Krebs solution. In this comparison, no difference
was found in protein dialysate concentrations. Thus, a differ-
ence in pH and/or buffer anion, both of which were present in
this comparison (Table 1) could not account for the increased
protein dialysate concentrations seen in group 1.
The third set of data (group 3) compared a normal Krebs
solution to a hyperosmolar Krebs solution. pH and buffer anion
were the same in the two solutions. Since again no difference in
dialysate protein concentrations were found, it does not appear
that osmolality changes alone could explain the differences
found in group 1. It is of interest that others have found that
going from commercial 1.5% dextrose solutions to 4.5% dex-
trose solutions did increase dialysate protein concentrations
[16].
Data for group 3 (Fig. 4) demonstrates that with both high and
normal osmolality dialysis solutions, protein concentrations in
the dialysate are very high in the first exchange. There is then a
progressive decrease in protein concentration with successive
exchanges, and a change from a normal to a high osmolality
solution or the converse, does not alter steady state levels. A
fall in dialysate protein concentration with successive ex-
changes has also been reported in intermittent peritoneal dialy-
sis studies which used one hyperosmolar commercial solution
[16]. The rat studies (Fig. 5) also demonstrate an initially high
protein concentration in the dialysate and a progressive fall with
successive exchanges. FITC-RSA concentrations, however,
started at a low value and then rose slightly with successive
exchanges. The FITC-RSA did not have pre-experiment time to
equilibrate in the interstitium or accumulate in the peritoneal
cavity. Therefore, these data suggest that with FITC-RSA in
the first few exchanges, there is an interstitial equilibration, and
then with subsequent exchanges there is a constant rate of
transfer of protein to the peritoneal cavity.
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The data from group 1 and the work of other investigators on
the role of the interstitial space for the passage of proteins was
the basis for the hypothesis tested in this paper. Under condi-
tions of normal hydration (normal osmolality) interstitial resist-
ance to protein movement is low and protein transfer would
occur easily. In the presence of the high osmolality dialysis
solutions, the interstitial space would become dehydrated.
Pathways for protein transport would become compressed
resulting in an increase in the resistance to protein movement
and a decrease in dialysate protein. This hypothesis was not
supported by the data from group 3 (Fig. 3). A difference in
osmolality did not produce a difference in steady state dialysate
protein concentrations.
If the decrease in dialysate protein with successive exchanges
(Fig. 4) is due to a dehydration of the interstitium as our
hypothesis would also predict, then we would expect in this plot
to get the greatest decreasing slope for the highest osmolality
solutions and the least slope for the lowest osmolality solution.
On the other hand, if the decrease in dialysate protein with
successive exchanges is due to a washout of residual protein,
then the slopes of the plots of dialysate protein versus the
exchange number should he the same with different osmolality
solutions. Group 3 data (Fig. 4) gave the same slopes for
different osmolality solutions suggesting that this is a washout
phenomena.
This conclusion is substantiated by the dialysis studies in the
rat (Fig. 5). In these experiments, there was a fall in the
dialysate protein concentration which had had time to accumu-
late in the peritoneuin (the total protein measurement, solid
line) but not in the protein which was acutely injected (FITC-
RSA, dashed line). Thus, both the human and rat experiments,
tend to refute the hypothesis that interstitial dehydration leads
to diminished protein transfer. But these data do not explain the
results obtained in group I which show a higher concentration
of protein when a normal osmolality Krebs solution is used for
dialysis. Such a difference cannot be substantiated by differ-
ences in the vasoactivity of the various solutions [1,4,5, 17]. It
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may he that the combination of a different pH and osmolality in
group I could have influenced protein binding and the availabil-
ity of appropriate water channels in the intcrstitium resulting in
an altered protein concentration in the dialysate. This alterna-
tive has not yet been tested.
Summary. Peritoneal dialysis studies were performed in
humans and rats to investigate the hypothesis that the high
osmolality of peritoneal dialysis solutions dehydrates the inter-
stitial tissue in the pcritoncal cavity resulting in a decrease in
dialysate protein concentration, Dialysis with solutions which
differed in osmolality, pH, and/or buffer anion indicated that
protein dialysate concentration is influenced by changes in two
or more of these factors hut that changes in one variable only
(osmolality, p1-I, or buffer anion alone) cannot produce these
effects. These studies also demonstrated that protein dialysate
concentration is very high during the first exchange of the day
and then progressively falls with subsequent exchanges. Our
data suggest that this phenomenon is due to a washout of
residual protein in the peritoneal cavity.
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